Functional basis for the glomerular alterations in uranyl nitrate acute renal failure

R. C. Blantz, J. C. Pelayo, L. C. Gushwa, R. R. Myers, A. P. Evan

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

We have examined the acute renal failure that occurs after uranyl nitrate administration in the rat and the specific effects of pretreatment of rats with angiotensin converting enzyme inhibitor (CEI), plasma volume expansion (PVE) after uranyl nitrate, and a combination of these treatments. We utilized a combination of micro-puncture measurements of glomerular hemodynamics, cage studies, and histologic examination of renal tissue to evaluate the degree of acute renal failure in all groups studied. Uranyl nitrate (UN) (25 mg/kg body wt) administration caused a reduction in the nephron filtration rate (SNGFR) (39.4 ± 1.6 to 24.8 ± 2.9 nl·min-1·g kidney wt-1, P < 0.02) as a result of a major decrease in the glomerular ultrafiltration coefficient (LpA) from control values (≥ 0.085 ± 0.008 to 0.035 ± 0.007 nl·sec-1·mm Hg-1·g kidney wt-1, P < 0.01). Treatments with CEI, PVE, and the combination of CEI and PVE in rats receiving UN restored LpA to normal values (> 0.061 ± 0.009, 0.091 ± 0.020, and 0.138 ± 0.020 nl·sec-1·mm Hg-1·g kidney wt-1, respectively). Cage studies revealed that CEI treatment prevented oliguria and resulted in major volume losses and reduction in weight. However, rats died after a similar period after UN, but probably by different mechanisms. Analysis of renal ultrastructure revealed equivalent tubular damage in all experimental groups. Alterations in LpA after UN are functional in nature and are potentially preventable and reversible by a combination of treatments with CEI and PVE.

Original languageEnglish (US)
Pages (from-to)733-743
Number of pages11
JournalKidney international
Volume28
Issue number5
DOIs
StatePublished - Jan 1 1985

Fingerprint

Uranyl Nitrate
Acute Kidney Injury
Kidney
Plasma Volume
Enzyme Inhibitors
Oliguria
Nephrons
Punctures
Angiotensin-Converting Enzyme Inhibitors
Weight Loss
Therapeutics
Hemodynamics

ASJC Scopus subject areas

  • Nephrology

Cite this

Functional basis for the glomerular alterations in uranyl nitrate acute renal failure. / Blantz, R. C.; Pelayo, J. C.; Gushwa, L. C.; Myers, R. R.; Evan, A. P.

In: Kidney international, Vol. 28, No. 5, 01.01.1985, p. 733-743.

Research output: Contribution to journalArticle

Blantz, R. C. ; Pelayo, J. C. ; Gushwa, L. C. ; Myers, R. R. ; Evan, A. P. / Functional basis for the glomerular alterations in uranyl nitrate acute renal failure. In: Kidney international. 1985 ; Vol. 28, No. 5. pp. 733-743.
@article{45edd2e4d2e847a99f7ad852829ae864,
title = "Functional basis for the glomerular alterations in uranyl nitrate acute renal failure",
abstract = "We have examined the acute renal failure that occurs after uranyl nitrate administration in the rat and the specific effects of pretreatment of rats with angiotensin converting enzyme inhibitor (CEI), plasma volume expansion (PVE) after uranyl nitrate, and a combination of these treatments. We utilized a combination of micro-puncture measurements of glomerular hemodynamics, cage studies, and histologic examination of renal tissue to evaluate the degree of acute renal failure in all groups studied. Uranyl nitrate (UN) (25 mg/kg body wt) administration caused a reduction in the nephron filtration rate (SNGFR) (39.4 ± 1.6 to 24.8 ± 2.9 nl·min-1·g kidney wt-1, P < 0.02) as a result of a major decrease in the glomerular ultrafiltration coefficient (LpA) from control values (≥ 0.085 ± 0.008 to 0.035 ± 0.007 nl·sec-1·mm Hg-1·g kidney wt-1, P < 0.01). Treatments with CEI, PVE, and the combination of CEI and PVE in rats receiving UN restored LpA to normal values (> 0.061 ± 0.009, 0.091 ± 0.020, and 0.138 ± 0.020 nl·sec-1·mm Hg-1·g kidney wt-1, respectively). Cage studies revealed that CEI treatment prevented oliguria and resulted in major volume losses and reduction in weight. However, rats died after a similar period after UN, but probably by different mechanisms. Analysis of renal ultrastructure revealed equivalent tubular damage in all experimental groups. Alterations in LpA after UN are functional in nature and are potentially preventable and reversible by a combination of treatments with CEI and PVE.",
author = "Blantz, {R. C.} and Pelayo, {J. C.} and Gushwa, {L. C.} and Myers, {R. R.} and Evan, {A. P.}",
year = "1985",
month = "1",
day = "1",
doi = "10.1038/ki.1985.192",
language = "English (US)",
volume = "28",
pages = "733--743",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Functional basis for the glomerular alterations in uranyl nitrate acute renal failure

AU - Blantz, R. C.

AU - Pelayo, J. C.

AU - Gushwa, L. C.

AU - Myers, R. R.

AU - Evan, A. P.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - We have examined the acute renal failure that occurs after uranyl nitrate administration in the rat and the specific effects of pretreatment of rats with angiotensin converting enzyme inhibitor (CEI), plasma volume expansion (PVE) after uranyl nitrate, and a combination of these treatments. We utilized a combination of micro-puncture measurements of glomerular hemodynamics, cage studies, and histologic examination of renal tissue to evaluate the degree of acute renal failure in all groups studied. Uranyl nitrate (UN) (25 mg/kg body wt) administration caused a reduction in the nephron filtration rate (SNGFR) (39.4 ± 1.6 to 24.8 ± 2.9 nl·min-1·g kidney wt-1, P < 0.02) as a result of a major decrease in the glomerular ultrafiltration coefficient (LpA) from control values (≥ 0.085 ± 0.008 to 0.035 ± 0.007 nl·sec-1·mm Hg-1·g kidney wt-1, P < 0.01). Treatments with CEI, PVE, and the combination of CEI and PVE in rats receiving UN restored LpA to normal values (> 0.061 ± 0.009, 0.091 ± 0.020, and 0.138 ± 0.020 nl·sec-1·mm Hg-1·g kidney wt-1, respectively). Cage studies revealed that CEI treatment prevented oliguria and resulted in major volume losses and reduction in weight. However, rats died after a similar period after UN, but probably by different mechanisms. Analysis of renal ultrastructure revealed equivalent tubular damage in all experimental groups. Alterations in LpA after UN are functional in nature and are potentially preventable and reversible by a combination of treatments with CEI and PVE.

AB - We have examined the acute renal failure that occurs after uranyl nitrate administration in the rat and the specific effects of pretreatment of rats with angiotensin converting enzyme inhibitor (CEI), plasma volume expansion (PVE) after uranyl nitrate, and a combination of these treatments. We utilized a combination of micro-puncture measurements of glomerular hemodynamics, cage studies, and histologic examination of renal tissue to evaluate the degree of acute renal failure in all groups studied. Uranyl nitrate (UN) (25 mg/kg body wt) administration caused a reduction in the nephron filtration rate (SNGFR) (39.4 ± 1.6 to 24.8 ± 2.9 nl·min-1·g kidney wt-1, P < 0.02) as a result of a major decrease in the glomerular ultrafiltration coefficient (LpA) from control values (≥ 0.085 ± 0.008 to 0.035 ± 0.007 nl·sec-1·mm Hg-1·g kidney wt-1, P < 0.01). Treatments with CEI, PVE, and the combination of CEI and PVE in rats receiving UN restored LpA to normal values (> 0.061 ± 0.009, 0.091 ± 0.020, and 0.138 ± 0.020 nl·sec-1·mm Hg-1·g kidney wt-1, respectively). Cage studies revealed that CEI treatment prevented oliguria and resulted in major volume losses and reduction in weight. However, rats died after a similar period after UN, but probably by different mechanisms. Analysis of renal ultrastructure revealed equivalent tubular damage in all experimental groups. Alterations in LpA after UN are functional in nature and are potentially preventable and reversible by a combination of treatments with CEI and PVE.

UR - http://www.scopus.com/inward/record.url?scp=0022371153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022371153&partnerID=8YFLogxK

U2 - 10.1038/ki.1985.192

DO - 10.1038/ki.1985.192

M3 - Article

C2 - 3003441

AN - SCOPUS:0022371153

VL - 28

SP - 733

EP - 743

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -